Risk of deep vein thrombosis and pulmonary embolism in asthma

European Respiratory Journal

Volumn 42, Issue 3, 2013, Pages 655-661

  Majoor, Christof J ^a   Kamphuisen, Pieter W ^b   Zwinderman, Aeilko H ^a   Brinke, Anneketen ^c   Amelink, Marijke ^a   Rijssenbeek Nouwens, Lucia ^d   Sterk, Peter J ^a   Büller, Harry R ^a   Bel, Elisabeth H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MEDICAL CENTER LEEUWARDEN   (Netherlands)

^d Dutch Asthma Centre   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INCIDENCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYNDROME DELINEATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE FACILITIES; ASTHMA; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROPORTIONAL HAZARDS MODELS; PULMONARY EMBOLISM; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84883514900     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00150312     Document Type: Article

References (32)

1. Del Rosso M, Fibbi G, Matucci Cerinic M. The urokinase-type plasminogen activator system and inflammatory joint diseases. Clin Exp Rheumatol 1999; 17: 485-498. (Pubitemid 29343639)
2. Saibeni S, Saladino V, Chantarangkul V, et al. Increased thrombin generation in inflammatory bowel diseases. Thromb Res 2010; 125: 278-282.
3. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010; 375: 657-663.
4. Matta F, Singala R, Yaekoub AY, et al. Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 2009; 101: 134-138.
5. Stein PD, Goldman J, Matta F, et al. Diabetes mellitus and risk of venous thromboembolism. Am J Med Sci 2009; 337: 259-264.
6. Rizkallah J, Man SF, Sin DD. Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. Chest 2009; 135: 786-793.
7. Brims FJ, Chauhan AJ, Higgins B, et al. Coagulation factors in the airways in moderate and severe asthma and the effect of inhaled steroids. Thorax 2009; 64: 1037-1043.
8. de Boer JD, Majoor CJ, van 't Veer C, et al. Asthma and coagulation. Blood 2012; 119: 3236-3244.
9. ten Brinke A, Zwinderman AH, Sterk PJ, et al. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004; 170: 601-605. (Pubitemid 39202200)
10. Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
11. National Institutes of Health, Heart, Lung, and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, 2010. http://ginasthma.org/local/uploads/files/GINA- Report-March13.pdf Date last accessed: July 1, 2013.
12. Naess IA, Christiansen SC, Romundstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5: 692-699. (Pubitemid 46563566)
13. Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trøndelag health study 1995-1997 (HUNT2): objectives, contents, methods and participation. Norsk Epidemiologi 2003; 13: 19-32.
14. Gottschalk A, Sostman HD, Coleman RE, et al. Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med 1993; 34: 1119-1126. (Pubitemid 23191328)
15. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 2004; 117: 19-25. (Pubitemid 38801482)
16. van Belle A, Büller HR, Huisman MV, et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA 2006; 295: 172-179. (Pubitemid 43076436)
17. Andersen PK, Borch-Johnsen K, Deckert T, et al. A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. Biometrics 1985; 41: 921-932.
18. Huerta C, Johansson S, Wallander MA, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-943. (Pubitemid 46762756)
19. Farmer RD, Lawrenson RA, Todd JC, et al. Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database. Hum Reprod Update 1999; 5: 688-706. (Pubitemid 30034892)
20. Undas A, Ciesla-Dul M, Drazkiewicz T, et al. Association between atopic diseases and venous thromboembolism: a case-control study in patients aged 45 years or less. J Thromb Haemost 2011; 9: 870-873.
21. Allenbach Y, Seror R, Pagnoux C, et al. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 2009; 68: 564-567.
22. Bertoletti L, Quenet S, Mismetti P, et al. Clinical presentation and outcome of venous thromboembolism in COPD. Eur Respir J 2012; 39: 862-868.
23. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181: 315-323.
24. Wenzel SE, Busse WW. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119: 14-21. (Pubitemid 46043380)
25. Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660.
26. Zöller B, Li X, Sundquist J, et al. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation 2011; 124: 1012-1020.
27. Levi M, van der Poll T. Inflammation and coagulation. Crit Care Med 2010; 38: Suppl. 2, S26-S34.
28. Hofstra JJ, Schouten M, Levi M. Thrombophilia and outcome in severe infection and sepsis. Semin Thromb Hemost 2007; 33: 604-609. (Pubitemid 47429313)
29. Smeeth L, Cook C, Thomas S, et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367: 1075-1079.
30. Wanner A, Mendes ES. Airway endothelial dysfunction in asthma and chronic obstructive pulmonary disease: a challenge for future research. Am J Respir Crit Care Med 2010; 182: 1344-1351.
31. Cosgriff SW, Diefenbach AF, Vogt W Jr. Hypercoagulability of the blood associated with ACTH and cortisone therapy. Am J Med 1950; 9: 752-756.
32. van Zaane B, Nur E, Squizzato A, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors. J Thromb Haemost 2010; 8: 2483-2493.